-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Terns Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from Q1 2020 to Q1 2025.
- Terns Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$24.4M, a 7.2% decline year-over-year.
- Terns Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$70M, a 3.9% decline from 2023.
- Terns Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$67.4M, a 37.2% decline from 2022.
- Terns Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$49.1M, a 17.4% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)